LDLR and Patent ductus arteriosus: Furthermore, ApoE promotes immune suppression in PDA primarily by stimulating LDLR on cancer cells and thus activates NF-κB signals to induce the production of immunosuppressive factors from tumor cells such as CXCL1 and CXCL5 (Kemp et al., 2021).